Background/Aims: Hypertension and hyperuricemia are closely associated with an intermingled cause and effect relationship. Additionally, urinary sodium and potassium excretion is related to blood pressure. Whether or not it is associated with urinary uric acid excretion is not clear. Therefore, we aim to study the association of urinary sodium and potassium with renal uric acid excretion in patients with CKD. Methods: A cross-sectional study of 428 patients with CKD recruited from our department was conducted. All patients were divided into hypertension and non-hypertension group. In these two groups, Spearman correlation and multiple linear regression analysis were used to study the correlation of urinary sodium and potassium with renal handling of uric acid. Results: According to multiple linear regression analysis, in hypertension group, fractional excretion of sodium (FEna) was negatively correlated with 24 hour urinary uric acid (24-hUur) and uric acid clearance rate (Cur) (beta coefficients [B]=-0.066, -0.182, respectively; both P<0.05), and positively correlated with fractional excretion of uric acid (FEur) (B=1.641, P<0.001). Additionally, fractional excretion of potassium (FEk) was positively correlated with FEur (B=0.576, P<0.001), but not related to 24-hUur and Cur (both P>0.05). And urinary sodium/potassium ratio (Una/k) was negatively related to 24-h Uur and Cur (B=-0.047, -0.159, both P<0.05), and positively related to FEur (B=0.578, P<0.05). Furthermore, FEna and FEk was still positively related to FEur in the lowest tertile of eGFR groups (both P<0.05), but not related in the second and highest tertile of eGFR groups (all P>0.05). In non-hypertension group, FEna was negatively correlated with 24-hUur (B=-0.589, P<0.05), but not related to Cur and FEur (both P>0.05). both FEk and Una/k was not
Introduction
Hyperuricemia is common in chronic kidney disease (CKD) and associated with the development and progression of CKD [1] [2] [3] . The primary pathophysiology of hyperuricemia is defective renal handling of uric acid, including reduced glomerular filtration rate or enhanced reabsorption or insufficient secretion of uric acid by renal tubules [4, 5] . Proximal renal tubular epithelial cells (PTECs) express ion and urate transport channels responsible for reabsorption and secretion of urate [6] . Until now, the molecular mechanism underlying renal transport of uric acid and what factors may be involved in this process is not yet fully understood. Moreover, urinary uric acid excretion in population with CKD is rarely studied.
High sodium intake is a serious public health challenge in worldwide due to its contribution to the high prevalence and concomitant risks of hypertension and cardiovascular disease [7] . A study in 102, 216 adults from 18 countries showed a nonlinear association of sodium and potassium excretion with blood pressure [8] . Hypertension is a frequent finding in CKD, and most patients develop hypertension when the glomerular filtration rate (GFR) declines [9] . In addition, blood pressure of patients with CKD was more sensitive to high sodium intake than persons with normal kidney function due to a diminished capacity to excrete sodium [10] . On the other hand, hypertension and hyperuricemia are closely associated with an intermingled cause and effect relationship [11, 12] . Early studies have reported that the reabsorption of uric acid and sodium by renal tubules are closely related, which may be associated with insulin resistance [13] . But clinical reports on the relationship between urinary sodium and uric acid excretion are few. Additionally, the relationship of urinary potassium with renal uric acid excretion is not clear. Therefore, in the present study, we analyzed the data from 428 adults with CKD divided into hypertension and nonhypertension groups to examine the association between urinary sodium and potassium excretion and renal handling of uric acid in a clinical setting. We look forward to a further understanding of the mechanisms of renal tubular transport of uric acid and the internal relationship between hypertension and hyperuricemia.
Materials and Methods

Study participants
In this cross-sectional study, 428 adult patients with CKD were admitted. Patients were excluded if they had taken drugs that could affect uric acid metabolism within the previous 2 weeks, such as diuretic, aspirin, losartan, cyclosporine, glucocorticoids, immunosuppressive agents, anti-tuberculosis drugs, sodium bicarbonate, levodopa, metformin, fenofibrate and UA-lowering agents, such as febuxostat, benzbromarone or allopurinol. Since these medicines CKD patients took could affect uric acid metabolism, thus interfering with the relationship between urinary sodium, potassium and uric acid, our protocol involved holding these agents for two weeks. Before collecting data, we carefully checked medical history of subjects in the electronic medical record system. If the subjects had stopped these medicines or changed to other drugs for at least two weeks, they had a chance to be included, which could make the effects of drugs on the results of the study minimized. All the patients were in a stable clinical condition. Those who had a history of kidney transplantation, dialysis, hereditary hyperuricemia, severe heart, lung or liver dysfunction, infection, tumor Fengqin et al.: Association of Urinary Na + and K + with Uric Acid and hematologic diseases, hyperparathyroidism and shock were also excluded. Furthermore, all patients avoided high purine, fructose, sodium, and potassium diet and alcohol for 5 days before the study. Our study was approved by the ethical review board, and it conformed to the ethics guidelines. Written informed consents were obtained from all subjects.
Clinical and laboratory measurements
A single 24 h urine sample was collected from each participant. All participants were instructed orally on the collection of 24 h urine samples. Each participant was provided with a three-liter plastic bottle. And they were asked to discard the first specimen in the morning, and from then on to collect all specimens for up to 24 h. Trained nurses were in charge of recording the starting and ending time of each specimen collection and interviewing about completeness using a standard questionnaire. All samples were immediately sent to the clinical laboratory for the analysis of the 24-h urinary levels of uric acid (Uur), sodium (Una), potassium (Uk), urinary glucose (Ug), urinary volume (UV), urinary creatinine (Ucr), urinary albumin (UALB). Urinary albumin to creatinine ratio (UACR) was calculated as UALB/Ucr. Fractional excretion of uric acid (FEur) was calculated as (Uur×Scr)/(SUA×Ucr)×100, expressed as percentage. Uric acid clearance rate (Cur) was calculated as Uur×UV/SUA. Fractional excretion of sodium (FEna) was calculated as (Una×Scr)/ (Sna×Ucr)×100, expressed as percentage. Fractional excretion of potassium (FEk) was calculated as (Uk×Scr)/(Sk×Ucr)×100, expressed as percentage. Urinary sodium/potassium ratio was calculated as Una/ Uk. 24-h Uur, Cur and Ug were corrected for the body surface area.
Height, weight and blood pressure were measured by trained nurses in a standardized way. Body mass index (BMI) was calculated as weight in kilograms divided by height in meters squared. After 12 hours of fasting on the day of collecting 24 hours of urine, morning venous blood was sampled for routine biochemistry, including the serum levels of sodium (Sna), potassium (Sk), uric acid (SUA), creatinine (Scr), urinary nitrogen (BUN), C-reactive protein (CRP), total cholesterol (TC), triglycerides (TG), high-density lipoprotein (HDL), low-density lipoprotein (LDL), fasting blood glucose (FBG), total carbon dioxide (TCO2) and hemoglobin A1c (HbA1c). The estimated glomerular filtration rate (eGFR) (milliliters per minute per 1.73 m 2 ), an indicator of renal function, was calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula [14] .
Diagnostic and grouping criteria
Hyperuricemia was defined as the serum level of uric acid >420µmol/L; Hypertension was defined as systolic blood pressure (SBP)≥140 mmHg, diastolic blood pressure (DBP) ≥90 mmHg, or use of antihypertensive medication according to self-report or to pharmacy data. Study participants were divided into hypertension group (H) and non-hypertension group (NH). In hypertension population, according to tertiles of eGFR, patients were divided into three groups (HG1: eGFR<33.9ml/min/ ). In hypertension group, according to tertiles of FEna, patients were divided into three groups (FEna1: FEna<0.92%; FEna2: 0.92%≤FEna≤1.88%; FEna3: FEna>1.88%). According to tertiles of FEk, patients were divided into three groups (FEk1: FEk<8.36%; FEk2: 8.36%≤FEk≤15.17%; FEk3: FEk>15.17%); According to tertiles of Una/k, patients were divided into three groups (Una/k1: Una/ k<3.86; Una/k2: 3.86≤Una/k≤5.40; Una/k3: Una/k>5.40).
Statistical analysis
The continuous variables are reported in means±SD and categorical variables are presented in percentages. In case of nonparametric data distribution medians with inter quartile range (IQR) are presented. Comparisons were made between groups using Student's t-test or one-way ANOVA. We used least significance difference (LSD) test if the variance was homogeneous, and we used Tamhane's T2 test if not. Non-normally distributed data was compared using Kruskall-Wallis test. Categorical data was compared 
Results
Characteristics of the study population and when stratified by tertiles of 24-h Uur
We included 428 participants with mean age 55.5±16.7 years and 219 males (51.2%). There were 254 hypertensive patients. General data are shown in Table 1 . Biochemical differences in different groups according to 24-h Uur tertiles are also summarized in Table  1 . Participants in the highest tertile of 24-hUur group had lower age, SUA, Sk, proportion of hypertension, Una/k, FEna, FEk and FEur, higher eGFR, UV and Cur than those in the lowest tertile of 24-h Uur group (all P<0.05, Table 1 ). Table 1 . Characteristics of the study population according to tertiles of 24-h Uur. * P<0.05, **P<0.01 vs. the Uur1 using the least significance difference (LSD) method if the variance is equal or the Tamhane's T2 method if the variance is not equal, using Kruskal-Wallis test in case of nonparametric data distribution. Numbers are mean±SD or proportion. For TG, CRP, 24-hUg, FEna, FEk, Una/k, Cur, and FEur, median and the 25th and 75th percentile are shown. Abbreviations: BMI, body mass index; eGFR, estimated glomerular filtration rate; CRP, C-reactive protein; TC, total cholesterol; TG, triglycerides; HDL, high-density lipoprotein; LDL, low-density lipoprotein; FBG, fasting blood glucose; SUA, serum uric acid; Sna, serum sodium; Sk, serum potassium; 24-hUg, 24-hour urinary glucose; 24-h Uur, 24-hour urinary uric acid excretion; FEna, fractional excretion of sodium; FEk, fractional excretion of potassium; Una/k, urinary sodium/potassium ratio; Cur, uric acid clearance rate; FEur, fractional excretion of uric acid Among the etiology of CKD, chronic glomerulonephritis (CGN) accounted for the highest proportion (71.3%, 305/428), followed by hypertensive nephropathy (HN) (13.1%, 56/428), and diabetic kidney disease (DKD) accounted for (11.7%, 50/428). In addition, polycystic kidney disease (PKD) and atherosclerotic renal arterial stenosis (ARAS) accounted for 8.6% (18/428) and 3.3% (7/428) . Among this population of CKD patients included in the study, calcium channel blockers, β blockers, statins, α-glucosidase inhibitor or insulin were used, and these agents were similar among groups.
Association of urinary sodium and potassium excretion with renal uric acid excretion
In hypertensive group, Spearman correlation analysis showed that FEna was negatively associated with 24- Table 2 , 3, and 4), after adjusting confounding factors in three models (model 1 adjusted for sex, age and BMI; model 2 plus eGFR and SUA; model 3 plus FBG, 24-hUg, TG, CRP, LDL, and TCO2).
In order to investigate how the association of FEna and FEk with FEur tracks with changes in eGFR, their relationship in three groups stratified by tertile of eGFR in hypertension and non-hypertension population was further analyzed as follows. 
Differences in urinary uric acid excretion according to tertiles of urinary sodium and potassium in hypertension group
Compared with the first tertile of FEna group, levels of 24-h Uur and Cur in the highest tertile of FEna group were lower (both P<0.001; Fig.1A and 1B) , and levels of FEur in the second tertile and highest tertile of FEna groups were higher (both P<0.001; Fig.1C ). And Fig. 2 ). FEur in the highest tertile of Una/k group was higher than that in the first tertile of Una/k group (P<0.001; Fig.3C ). But there was no statistical difference for levels of 24-h Uur and Cur in different tertiles of Una/k groups (P>0.05; Fig. 3A and B) .
Discussion
To our knowledge, this study is the first to investigate the association of urinary sodium and potassium with renal handling of uric acid among patients with CKD. After adjusting for many potential confounders, we found that in hypertension group, fractional excretion of sodium (FEna) was negatively correlated with 24-hUur and Cur, and positively correlated Fig. 3 . Differences in 24-h Uur, Cur and FEur according to tertiles of Una/k in hypertension group. Levels of 24-h Uur (A), Cur (B) and FEur (C) were compared according to tertiles of Una/k using one-way ANOVA. FEur in the highest tertile of Una/k group was higher than that in the first tertile of Una group. But there was no statistical difference for levels of 24-h Uur and Cur in different tertiles of Una/k groups. Una/k1: Una/ k<3.86; Una/k2: 3.86≤Una/k≤5.40; Una/k3: Una/k>5.40. *P<0.05, ** P<0.01 vs. Una/k1. Abbreviations: 24-h Uur, 24-hour urinary uric acid excretion; Cur, uric acid clearance rate; FEur, fractional excretion of uric acid; Una/k: urinary sodium/potassium ratio. ANOVA, analysis of variance. Epidemiological studies have shown an association between high sodium and low potassium intake or a high urinary sodium/potassium ratio and high BP or cardiovascular disease [8, [15] [16] [17] , which may play an important role in the pathogenesis of hypertension independent of cardiovascular risk factors. In this study, by analyzing CKD patients with and without hypertension, we observed that Una/k was negatively associated with 24-h Uur and Cur, and positively associated with FEur in hypertensive patients. However, these associations disappeared in non-hypertensive patients, after adjusting for many potential confounders. It suggested that urinary sodium and potassium excretion was closely related to renal handling of uric acid in hypertensive patients, which may be one of the mechanisms of the relationship between hyperuricemia and hyperuricemia. It is expected to help reduce the risk of hyperuricemia through a low sodium and high potassium diet.
Fig. 2 Differences in 24-h Uur, Cur and FEur according to tertiles of FEk in hypertension group
The current relationship of urinary sodium with renal handling of uric acid is not clear. Recently, Perez-Ruiz found that renal clearance of uric acid was positively with fractional excretion of sodium, conducted in a untreated and non-diabetic gout patients [18] . In contrast, we observed that FEna was negatively correlated with Cur and 24-h Uur, and both FEna and FEk was positively correlated with FEur in hypertensive group with low eGFR. This seemed to reflect the fact that FEna and FEur increased adaptively, 24-hUur and Cur decreased with the decline of renal function in our CKD patients, according to our data and previous studies [19, 20] . However, FEna and FEk was not related to FEur in hypertension population with early and medium-term decline in renal function (eGFR≥33.9ml/min/1.73m 2 ) and nonhypertension population in our study. One potential explanation was that the mechanism of hypertension and hyperuricemia in CKD subjects with severely impaired GFR may relate to the direct effects of low GFR to impair sodium, potassium and uric acid handling [3, 21, 22] ; as a consequence, this may be the main mechanism responsible for association FEna and FEk with FEur in hypertension patients as GFR decreased obviously, which may explain the whole relationship. Gout patients in the study above had normal renal function, which made a difference from ours. Indeed, early study also indicated that high serum uric acid levels were independently associated with increased proximal tubular sodium reabsorption in men workers. Concurrently, it also suggested that altered tubular sodium handling and uric acid metabolism were consistent with hyperinsulinemia, and insulin resistance could be the possible pathophysiological link [23] . Furthermore, subsequent researches observed a reduction in renal handling of both uric acid and sodium in healthy humans with acute physiological hyperinsulinemia and in hypertension [13] . According to previous studies, hyperinsulinemia could activate uric acid transporters and increase reabsorption of sodium and potassium in hypertensive subjects [24] . Moreover, hyperinsulinemia increases intracellular pH and activates the renal tubular Na⁺-H⁺ exchange, followed by reabsorption of anions and urate salts [25, 26] . However, in the present study, insulin resistance was not incorporated into the analysis due to absence of laboratory indicators reflecting insulin resistance, and further clinical and experiment studies should be done.
It is well known that the mechanism of renal tubular reabsorption and secretion of uric acid is complicated, mediated by various uric acid transporters at the apical and basolateral membrane of proximal epithelial tubular cells [27] . Uric acid reabsorption overall is supposed to be a tertiary active transport process based on sodium reabsorption, whereby the basolateral Na⁺-K⁺-ATPase generates a Na⁺ gradient (primary active transport) that drives a number of apical urate transporters [6] . Up to date, urate transporter 1(URAT1) and glucose transporter-like protein-9 (GLUT9) are the best characterized urate transporters, mainly responsible for renal tubular reabsorption [27] . URAT1 (SLC22A12) is a major transporter of the organic anions transporter (OAT) family [28] , and there is evidence for indirect coupling of sodium [29] . Since the molecular cloning of URAT1 (SLC22A12), several membrane proteins relevant to the transport of urate have been identified, such as SMCT1(SLC5A8) and SMCT2(SLC5A12). These proteins are sodium-dependent monocarboxylic acid transporters located in the proximal tubule that transport lactate and nicotinate into the proximal tubule cell [30, 31] . Given these data, urinary sodium may have an inherent relationship with the reabsorption of uric acid by renal tubules. Indeed, CKD patients often present low urinary excretion of sodium, which was not only the main pathogenic basis of hypertension [22, 32] , but also may be one of the mechanisms that affect the level of serum uric acid.
Currently, no population-based studies have been done on the association between urinary potassium excretion and renal handling of uric acid. In our study, we documented that urinary potassium was correlated with urinary excretion of uric acid in CKD patients with hypertension, after adjusting for potential confounders. Animals studies on physiological mechanism of renal tubule excretion of uric acid can explain our finding. In the perfused snake tubule preparation, Dantzler observed that the presence of K⁺ in the bath was necessary to attain appreciable transport of uric acid, suggesting that uric acid is specifically stimulated by K⁺ in the snake [33] . On the other hand, Chonko found that 10⁻⁴ M ouabain almost completely inhibited the secretory flux of uric acid in the rabbit [34] . And ouabain could inhibited the activity of Na⁺-K⁺-ATPase and transport of K + [35] , which suggested urinary potassium was associated with tubular uric acid transport. In addition, a study on mechanisms of uric acid transport were investigated in human renal brush-border membrane vesicles, and it observed that uric acid transport in brush border membrane vesicle (BBMV) of human kidney depended on membrane potential. When an inward-positive potential was induced by imposing a K⁺ gradient in the presence of valinomycin, a stimulation of uric acid uptake was obtained [36] , which may be also one of the evidences of correlation between potassium transport and uric acid transport in renal tubule.
Some potential limitations of the present study should be noted. First, the cross-sectional nature of the present study makes it hard to establish the causal relationship between urinary sodium and potassium excretion with renal handling of uric acid. Second, a single urine collection might have overestimated or underestimated the actual urinary excretion of uric acid, sodium and potassium in the CKD population. Finally, we did not explore the effects of specific etiology of CKD on uric acid excretion. Nonetheless, there are still several noteworthy strengths to our present study. Most importantly, strict exclusion criteria based on medical histories and routine laboratory findings and careful adjustments for possible confounders was applied. In addition, we used combined indexes of urinary sodium, potassium and uric acid for the analysis, which was more comprehensive and representative.
Conclusion
The present study reported that in CKD patients, urinary sodium and potassium excretion was closely correlated with renal handling of uric acid after adjusting for multiple confounders, which was pronounced in hypertensive patients. This phenomenon may be one of the mechanisms of the relationship between hyperuricemia and hyperuricemia. Further research is needed to confirm it. It is expected to help reduce the risk of hyperuricemia through a low sodium and high potassium diet. 
